End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
781,000 KRW | +0.77% | -2.62% | +2.76% |
04-25 | Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe | MT |
04-25 | Samsung Biologics Posts Higher Q1 Profit, Sales | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.76% | 40.17B | |
-3.72% | 86.16B | |
-17.49% | 31.47B | |
+54.44% | 25.24B | |
-13.13% | 15.82B | |
-9.12% | 11.96B | |
-15.45% | 11.89B | |
-42.56% | 11.61B | |
+4.87% | 8.84B | |
-2.11% | 7.93B |
- Stock Market
- Equities
- A207940 Stock
- News Samsung Biologics Co.,Ltd.
- Samsung Biologics's Net Income Declines in Q3